CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-30 | Kramer Robin Chief Accounting Officer | Option exercise | +252 | 4,095.75 | ||
| 2023-06-30 | Kramer Robin Chief Accounting Officer | Shares withheld for taxes | −122 | $284.85 | $35K | 3,973.75 |
| 2023-06-30 | Kramer Robin Chief Accounting Officer | Option exercise · Restricted Stock Unit | −252 | 0 | ||
| 2023-06-30 | Singhal Priya Head of Development | Option exercise 10b5-1 | +315 | 3,158.09 | ||
| 2023-06-30 | Singhal Priya Head of Development | Shares withheld for taxes 10b5-1 | −153 | $284.85 | $44K | 3,005.09 |
| 2023-06-30 | Singhal Priya Head of Development | Option exercise · Restricted Stock Unit 10b5-1 | −315 | 0 | ||
| 2023-06-26 | SHERWIN STEPHEN A Director | Grant or award | +960 | 18,738 | ||
| 2023-06-26 | Rowinsky Eric K Director | Grant or award | +960 | 20,174 | ||
| 2023-06-26 | Mantas Jesus B Director | Grant or award | +960 | 6,048 | ||
| 2023-06-26 | LANGER SUSAN Director | Grant or award | +960 | 1,419.1 | ||
| 2023-06-26 | HAWKINS WILLIAM A Director | Grant or award | +960 | 5,150 | ||
| 2023-06-26 | Freire Maria C Director | Grant or award | +960 | 3,105 | ||
| 2023-06-26 | DORSA CAROLINE Director | Grant or award | +1,580 | 24,822 | ||
| 2023-05-01 | Keeney Adam Head of Corporate Development | Grant or award · Restricted Stock Unit | +2,815 | 2,815 | ||
| 2023-04-28 | Gregory Ginger EVP, Human Resources | Sale 10b5-1 | −2,681 | $300.00 | $804K | 8,482.72 |
| 2023-04-04 | Singhal Priya Head of Development | Sale 10b5-1 | −91 | $277.11 | $25K | 2,843.09 |
| 2023-03-31 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise | +239 | 5,818.29 | ||
| 2023-03-31 | Murphy Nicole Head of Pharm Ops and Tech | Shares withheld for taxes | −116 | $278.03 | $32K | 5,702.29 |
| 2023-03-31 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise · Restricted Stock Unit | −239 | 240 | ||
| 2023-03-28 | Singhal Priya Head of Development | Sale | −568 | $270.06 | $153K | 2,842.39 |
Page 21 of 29 · 579 trades